BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 45 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $8,000 | -63.6% | 34,223 | -18.2% | 0.00% | – |
| Q2 2022 | $22,000 | -51.1% | 41,813 | +91.8% | 0.00% | – |
| Q1 2022 | $45,000 | -95.9% | 21,800 | -91.6% | 0.00% | – |
| Q4 2021 | $1,088,000 | -42.3% | 260,800 | +28.7% | 0.00% | – |
| Q3 2021 | $1,884,000 | -63.2% | 202,590 | -28.7% | 0.00% | – |
| Q2 2021 | $5,114,000 | – | 283,972 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJ WEALTH STRATEGIES, LLC | 36,001 | $0 | 0.00% |